[1] Yang L, Xing G, Wang L, et al. Acute Kidney Injury in China: A Cross-Sectional Survey. Lancet (2015) 386(10002):1465–71. doi: 10.1016/S0140-6736(15)00344-X
[2] B.J. Nankivell, D.R. Kuypers, Diagnosis and prevention of chronic kidney allograft loss, The Lancet. 378 (2011) 1428-37.
[3] Leditzke K, Wagner MEH, Neunaber C, Clausen JD, Winkelmann M. Neutrophil Gelatinase-associated Lipocalin Predicts Post-traumatic Acute Kidney Injury in Severely Injured Patients.?In Vivo. 2021;35(5):2755-2762. doi:10.21873/invivo.12560
[4] Neyra JA, Hu MC, Moe OW. Klotho in Clinical Nephrology: Diagnostic and Therapeutic Implications.?Clin J Am Soc Nephrol. 2020;16(1):162-176. doi:10.2215/CJN.02840320
[5] Zhou H, Pu S, Zhou H, Guo Y. Klotho as Potential Autophagy Regulator and Therapeutic Target.?Front Pharmacol. 2021;12:755366. Published 2021 Oct 19. doi:10.3389/fphar.2021.755366
[6] Mencke R, Harms G, Moser J, et al. Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease.?JCI Insight. 2017;2(20):e94375. Published 2017 Oct 19. doi:10.1172/jci.insight.94375
[7] Hu MC, Shi M, Zhang J, et al. Renal Production, Uptake, and Handling of Circulating αKlotho.J Am Soc Nephrol. 2016;27(1):79-90. doi:10.1681/ASN.2014101030
[8] Mencke R, Harms G, Moser J, et al. Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease.?JCI Insight. 2017;2(20):e94375. Published 2017 Oct 19. doi:10.1172/jci.insight.94375
[9] ShiM, Flores B, Gillings N, et al. : aKlotho mitigates progression of AKI to CKD through activation of autophagy. J Am Soc Nephrol 27: 2331–2345, 2016
[10] Koza Y. Acute kidney injury: current concepts and new insights. J Inj Violence Res. 2016 Jan;8(1):58-62. doi: 10.5249/jivr.v8i1.610. PMID: 26804946; PMCID: PMC4729334
[11] Musso CG, Giordani MC, Imperiali N. Aging Kidney Transplantation. Rev Invest Clin. 2016;68(2):68-74.
[12] Thongprayoon C, Neyra JA, Hansrivijit P, et al. Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis. J Clin Med. 2020 Jun 12;9(6):1834. doi: 10.3390/jcm9061834. PMID: 32545510; PMCID: PMC7355868.
[13] Wojtaszek E, Oldakowska-Jedynak U, Kwiatkowska M, Glogowski T, Malyszko J. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation. Oxid Med Cell Longev. 2021 Feb 11;2021:6651367. doi: 10.1155/2021/6651367. PMID: 33628373; PMCID: PMC7895596.
[14] Scheuermann U, Babel J, Pietsch UC, et al. Recipient obesity as a risk factor in kidney transplantation.?BMC Nephrol. 2022;23(1):37. Published 2022 Jan 18. doi:10.1186/s12882-022-02668-z
[15] Castellano G, Intini A, Stasi A, et al. Complement modulation of anti-aging factor klotho in ischemia /reperfusion injury and delayed graft function. Am J Transplant. 2016;16(1):325-333.
[16] Li X, Lu P, Shao XF, Jiang T, Liu F, Li G. Klotho Regulates Epithelial-to-Mesenchymal Transition In Vitro via Wnt/β-Catenin Pathway and Attenuates Chronic Allograft Dysfunction in a Rat Renal Transplant Model. Ann Transplant. 2021 Mar 19;26:e930066. doi: 10.12659/AOT.930066. PMID: 33737505; PMCID: PMC7986726.
[17] Axelrod DA, Cheungpasitporn W, Bunnapradist S, et al. Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients.?Kidney Med. 2021;4(1):100377. Published 2021 Oct 22. doi:10.1016/j.xkme.2021.08.012
[18] Koza Y. Acute kidney injury: current concepts and new insights.?J Inj Violence Res. 2016;8(1):58-62. doi:10.5249/jivr.v8i1.610
[19] M.C. Hu, M. Shi, N. Gillings, et al., Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy, Kidney International. 91 (2017) 1104-14.70
[20] Hegde A, Denburg MR, Glenn DA. Acute Kidney Injury and Pediatric Bone Health. Front Pediatr. 2021 Feb 9;8:635628. doi: 10.3389/fped.2020.635628. PMID: 33634055; PMCID: PMC7900149.
[21] Zhou X, Li Sy, Wang Z, Yu L, Jiang H. Klotho protein: A potential therapeutic agent during myocardial ischemia and reperfusion.?Int J Cardiol. 2015;191:227-228. doi:10.1016/j.ijcard.2015.05.029
[22] Mo M, Pan L, Huang Z, Liang Y, Liao Y, Xia N. Development and Validation of a Prediction Model for Survival in Diabetic Patients With Acute Kidney Injury.?Front Endocrinol (Lausanne). 2021;12:737996. Published 2021 Dec 22. doi:10.3389 /fendo. 2021.737996
[23] Franzin R, Stasi A, Fiorentino M, et al. Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage [published correction appears in Front Immunol. 2021 Jan 08;11:630855].?Front Immunol. 2020;11:734.
[24] Kezi? A, Stajic N, Thaiss F. Innate Immune Response in Kidney Ischemia/ Reperfusion Injury: Potential Target for Therapy.?J Immunol Res. 2017;2017:6305439. doi:10.1155/2017/6305439
[25] Lemos NE, Dieter C, Carlessi R, et al. Renal effects of exendin-4 in an animal model of brain death.?Mol Biol Rep. 2019;46(2):2197-2207. doi:10.1007/s11033-019-04674-1
[26] Franzin R, Stasi A, Fiorentino M, Simone S, Oberbauer R, Castellano G, Gesualdo L. Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials. Front Immunol. 2021 Jul 6;12:673562.
[27] Wei J, Wang Y, Zhang J, Wang L, Fu L, Cha BJ, Buggs J, Liu R. A mouse model of renal ischemia-reperfusion injury solely induced by cold ischemia. Am J Physiol Renal Physiol. 2019 Sep 1;317(3): F616 -F622.
[28] Smith SF, Hosgood SA, Nicholson ML. Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells.?Kidney Int. 2019;95(1):50-56. doi:10.1016/j.kint.2018.10.009.
[29] Passov A, Ilmakunnas M, Pihlajoki M, et al. Neutrophil gelatinase-associated lipocalin does not originate from the kidney during reperfusion in clinical renal transplantation.?Intensive Care Med Exp. 2021;9(1):56. Published 2021 Nov 22. doi:10.1186/s40635-021-00422-7
[30] Bahl D, Haddad Z, Datoo A, Qazi YA. Delayed graft function in kidney transplantation.?Curr Opin Organ Transplant. 2019;24(1):82-86.
[31] Gifford CC, Lian F, Tang J, et al. PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-β1-receptor signaling.FASEB J. 2021;35(7):e21725. doi:10.1096/fj.202002652RR.
[32] Palmisano A, Gandolfini I, Delsante M, et al. Acute Kidney Injury (AKI) before and after Kidney Transplantation: Causes, Medical Approach, and Implications for the Long-Term Outcomes.?J Clin Med. 2021;10(7):1484. Published 2021 Apr 2. doi:10.3390/jcm10071484
[33] Kuro-O M. The Klotho proteins in health and disease.?Nat Rev Nephrol. 2019;15(1):27-44.doi:10.1038/s41581-018-0078-3.
[34]Li Y, Liu Y, Huang Y, et al.. IRF-1 promotes renal fibrosis by downregulation of Klotho. FASEB J. 2020 Mar;34(3):4415-4429. doi: 10.1096/fj.201902446R. Epub 2020 Jan 21. PMID: 31965641.
[35] L. Zhou, H. Mo, J. Miao, et al. Klotho ameliorates kidney injury and fibrosis and normalizes blood pressure by targeting the renin-angiotensin system, The American journal of pathology. 185 (2015) 3211-23.
[36] H. Sugiura, T. Yoshida, S. Shiohira, et al. Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis, American Journal of Physiology-Renal Physiology. 302 (2012) F1252-F64.
[37] Figuer A, Bodega G, Tato P, et al. Premature Aging in Chronic Kidney Disease: The Outcome of Persistent Inflammation beyond the Bounds. Int J Environ Res Public Health. 2021 Jul 29;18(15):8044. doi: 10.3390/ijerph18158044. PMID: 34360333; PMCID: PMC8345753.
[38] Zeng Y, Wang PH, Zhang M, Du JR. Aging-related renal injury and inflammation are associated with downregulation of Klotho and induction of RIG-I/NF-κB signaling pathway in senescence-accelerated mice.?Aging Clin Exp Res. 2016;28(1):69-76. doi:10.1007/s40520-015-0371-y
[39] Nakanishi K, Nishida M, Taneike M, et al.. Serum Klotho Levels Contribute to the Prevention of Disease Progression.?Int J Gen Med. 2021;14:229-236. Published 2021 Jan 22. doi:10.2147/IJGM.S291437
[40] Gao D, Zuo Z, Tian J, et al. Activation of SIRT1 Attenuates Klotho Deficiency-Induced Arterial Stiffness and Hypertension by Enhancing AMP-Activated Protein Kinase Activity. Hypertension. 2016 Nov;68(5):1191-1199. doi: 10.1161/HYPERTENSIONAHA.116.07709. Epub 2016 Sep 12. PMID: 27620389; PMCID: PMC5063709.
[41] Pedersen L, Pedersen SM, Brasen CL, Rasmussen LM. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays. Clin Biochem. 2013;46(12):1079-1083.
[42] Mace ML, Olgaard K, Lewin E. New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis.?Int J Mol Sci. 2020;21(22):8810. Published 2020 Nov 20. doi:10.3390/ijms21228810
[43] Bian A, Neyra JA, Zhan M, Hu MC. Klotho, stem cells, and aging. Clin Interv Aging. 2015;10:1233-1243
[44] Deng G, Liu D. Klotho: A Promising Biomarker Closely Related to Kidney Transplant.?Exp Clin Transplant. 2018;16(3):253-258. doi:10.6002/ect.2017.0329
[45] Donate-Correa J, Henriquez-Palop F, Martin-Nunez E, et al. Effect of paricalcitol on FGF-23 and Klotho in kidney transplant recipients. Transplantation. 2016;100(11):2432-2438.
[46] Kim SM, Han A, Ahn S, Min SI, Min SK, Ha J. Klotho as a potential predictor of deceased donor kidney transplantation outcomes. Ann Surg Treat Res. 2020 Jun;98(6):332-339. doi: 10.4174/astr.2020.98.6.332. Epub 2020 May 28. PMID: 32528913; PMCID: PMC7263887.
[47] Infante B, Bellanti F, Correale M, et al. mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction. Aging (Albany NY). 2021 Mar 23;13(6):8026-8039. doi: 10.18632/aging.202863. Epub 2021 Mar 23. PMID: 33758105; PMCID: PMC8034974.
[48] Puttarajappa C, Hariharan S. FGF-23 Klotho Axis: Will Intervention Improve Kidney Transplant Outcomes?.?Transplantation. 2016;100(11):2246-2247.
[49] Sopjani M, Rinnerthaler M, Kruja J, Dermaku-Sopjani M. Intracellular signaling of the aging suppressor protein Klotho. Curr Mol Med. 2015;15(1):27-37
[50] Li SS, He AL, Deng ZY, Liu QF. Ginsenoside-Rg1 Protects against Renal Fibrosis by Regulating the Klotho/TGF-β1/Smad Signaling Pathway in Rats with Obstructive Nephropathy. Biol Pharm Bull. 2018;41(4):585-591. doi: 10.1248/bpb.b17-00934. PMID: 29607931.
[51] Raeisi S, Ghorbanihaghjo A, Argani H, et al. The Effects of Valsartan on Renal Klotho Expression and Oxidative Stress in Alleviation of Cyclosporine Nephrotoxicity [published online ahead of print, 2017 Jun 23] [retracted in: Transplantation. 2017 Jul; 101(7):e230].?
[52] Piao SG, Kang SH, Lim SW, et al. Influence of N-acetylcysteine on Klotho expression and its signaling pathway in experimental model of chronic cyclosporine nephropathy in mice. Transplantation. 2013;96(2):146-153.
